Skip to main content
. 2018 Jun 25;7(7):160. doi: 10.3390/jcm7070160

Figure 1.

Figure 1

(A) The comparison of NLR (neutrophile/lymphocyte ratio) values in Group 1 (lung cancer patients) and Group 2 (control cases); (B) The comparison of PLR (platelet/lymphocyte ratio) values in Group 1 and Group 2.